Determining how the G1/S cell cycle transition regulates the homeostasis of adult intestinal stem cells

确定 G1/S 细胞周期转变如何调节成体肠道干细胞的稳态

基本信息

  • 批准号:
    9899107
  • 负责人:
  • 金额:
    $ 5.35万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2018
  • 资助国家:
    美国
  • 起止时间:
    2018-12-01 至 2020-08-31
  • 项目状态:
    已结题

项目摘要

Project Summary Regulation of the cell cycle of adult stem cells is crucial to maintaining tissue integrity. Cells irreversibly commit to division at the G1/S transition; however, how G1/S transition regulates adult stem cell cycles is currently unknown. I propose to study the molecular basis of how the G1/S transition is regulated in intestinal stem cell (ISC), which have physiologically high rates of proliferation. I will use intestinal organoid cultures as ex vivo models of ISC proliferation and intestinal homeostasis. Organoids are especially suited to this question because they are amenable to long-term live-cell imaging, while still retaining much of the stem cell physiology of their in vivo counterparts. My preliminary studies suggest that ISCs are especially sensitive to inhibition of Cyclin D/CDK4/6, a group of cyclin/CDK complexes that are key regulators of the G1/S transition. I propose to use live three-dimensional imaging intestinal organoids to investigate how the G1/S transition regulates ISC cell cycle and organoid homeostasis. (Aim 1) In collaboration with Dr. Prisca Liberali in the Friedrich Miescher Institute in Basel, I will learn and use light-sheet microscopy to perform long-term live-cell imaging on organoids expressing cell cycle and cell stemness reporters. This allows me to directly measure cell cycling dynamics in ICSs during CDK4/6 inhibition. For this aim, I will also develop computational image analysis tools to analyze large-scale 4-dimensional image data. (Aim 2) I will investigate the molecular mechanism that underlies G1/S transition in ISCs. To test that the cell cycle phenotype seen in ISCs during CDK4/6 inhibition is mediated by its known substrate, retinoblastoma protein (RB), I will specifically interfere with a motif in RB bound by Cyclin D, to see if RB phosphorylation specifically by Cyclin D/CDK4/6 is necessary for proper ISC G1/S control. Furthermore, I will test if expression levels of Cyclin D and RB also couple the G1/S transition to cell size in ISCs, by perturbing the expression levels of CDK4/6, Cyclin D, and RB, I and examining how ISC cell size distribution changes. Finally, I will investigate whether downstream cell fates are affected by ISCs that experience cell cycle disruption due to CDK4/6 inhibition, to see how cell-type homeostasis may also be affected by the G1/S transition. This project will elucidate the mechanisms used by adult stem cells to regulate their G1/S transition, an important problem in both developmental biology and cancer.
项目摘要 成体干细胞的细胞周期调控对维持组织完整性至关重要。细胞 在G1/S转换时不可逆转地承诺分裂;然而,G1/S转换如何调节 成体干细胞周期目前尚不清楚。我打算研究 G1/S转换在肠干细胞(ISC)中受到调节,其具有生理上高的转化率。 增殖我将使用肠类器官培养物作为ISC增殖的离体模型, 肠内稳态类器官特别适合这个问题,因为它们是 适合长期活细胞成像,同时仍然保留了大部分干细胞生理学, 它们的体内对应物。我的初步研究表明,ISCs对 抑制细胞周期蛋白D/CDK 4/6,一组细胞周期蛋白/CDK复合物,是细胞周期蛋白的关键调节因子。 G1/S转换。我建议使用活体三维成像肠道类器官, 研究G1/S转换如何调节ISC细胞周期和类器官稳态。(Aim第一章 在与巴塞尔的弗里德里希·米舍尔研究所的普里斯卡·利伯拉里博士的合作中,我将学习 并使用光片显微镜对表达 细胞周期和细胞干细胞报告基因。这让我可以直接测量细胞循环动力学 在ICSs中,CDK 4/6抑制期间。为了这个目标,我也将开发计算图像分析 分析大规模四维图像数据的工具。(Aim(2)研究分子 ISC中G1/S转变的基础机制。为了测试在细胞周期中观察到的细胞表型, CDK 4/6抑制期间的ISCs由其已知底物视网膜母细胞瘤蛋白(RB)介导, 将特异性干扰RB中与细胞周期蛋白D结合的基序,以观察RB磷酸化 特别是通过细胞周期蛋白D/CDK 4/6是必要的适当ISC G1/S控制。此外,我将 测试细胞周期蛋白D和RB的表达水平是否也将G1/S转变与ISCs中的细胞大小相关联, 通过干扰CDK 4/6、Cyclin D和RB,I的表达水平, 尺寸分布变化。最后,我将研究下游细胞命运是否受到影响, 由于CDK 4/6抑制而经历细胞周期破坏的ISC,以观察细胞类型 体内平衡也可能受到G1/S转换的影响。该项目将阐明 成体干细胞用于调节其G1/S转换的机制,这是成体干细胞研究中的一个重要问题。 发育生物学和癌症。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SHICONG XIE其他文献

SHICONG XIE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SHICONG XIE', 18)}}的其他基金

Determining the molecular mechanism controlling cell size in mammalian epithelia
确定控制哺乳动物上皮细胞大小的分子机制
  • 批准号:
    10038447
  • 财政年份:
    2020
  • 资助金额:
    $ 5.35万
  • 项目类别:
Determining the molecular mechanism controlling cell size in mammalian epithelia
确定控制哺乳动物上皮细胞大小的分子机制
  • 批准号:
    10251288
  • 财政年份:
    2020
  • 资助金额:
    $ 5.35万
  • 项目类别:
Determining how the G1/S cell cycle transition regulates the homeostasis of adult intestinal stem cells
确定 G1/S 细胞周期转变如何调节成体肠道干细胞的稳态
  • 批准号:
    9607770
  • 财政年份:
    2018
  • 资助金额:
    $ 5.35万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 5.35万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 5.35万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 5.35万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 5.35万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 5.35万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 5.35万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 5.35万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 5.35万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 5.35万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 5.35万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了